A new study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2.
source https://www.sciencedaily.com/releases/2021/03/210308131712.htm
Tuesday, 9 March 2021
Related Posts
Nanotech OLED electrode liberates 20% more light, could slash display power consumptionA new electrode that could free up 20% more light from organic light-e… Read More
More intense predation in the tropics can limit marine invasionsMarine biologists tested predictions about biological invasions, first… Read More
One 'ring' to rule them all: Curious interlocked molecules show dual responseScientists design polymers infused with a stress-sensitive molecular u… Read More
Unbroken: New soft electronics don't break, even when puncturedA team of researchers has created a new type of soft electronics, pavi… Read More
Engineered yeast could expand biofuels' reachResearchers found a way to reduce cellulosic feedstocks' toxicity to y… Read More
Scientists use NASA satellite data to track ocean microplastics from spaceScientists have developed an innovative way to use NASA satellite data… Read More
0 comments: